These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7418714)

  • 1. Dose dependent methotrexate elimination following bolus intravenous injection.
    Lawrence JR; Steele WH; Stuart JF; McNeill CA; McVie JG; Whiting B
    Eur J Clin Pharmacol; 1980 May; 17(5):371-4. PubMed ID: 7418714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits after intravenous administration.
    Chen ML; Chiou WL
    J Pharmacokinet Biopharm; 1983 Oct; 11(5):499-513. PubMed ID: 6668556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate and 7-hydroxy-methotrexate pharmacokinetics following intravenous bolus administration and high-dose infusion of methotrexate.
    Bore P; Bruno R; Lena N; Favre R; Cano JP
    Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1385-90. PubMed ID: 3500051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary pH and urine flow independent renal clearance of methotrexate in dogs.
    Lui CY; Lee MG; Chiou WL
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):159-71. PubMed ID: 4057055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonlinear renal elimination kinetics of methotrexate due to saturation of renal tubular reabsorption.
    Hendel J; Nyfors A
    Eur J Clin Pharmacol; 1984; 26(1):121-4. PubMed ID: 6714284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance studies of methotrexate in dogs after multiple-rate infusion.
    Lui CY; Lee MG; Chiou WL
    Cancer Res; 1985 Apr; 45(4):1545-8. PubMed ID: 3978622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-vindesine association in head and neck cancer: modification of methotrexate's hydroxylation in presence of vindesine.
    Bore P; Lena N; Imbert AM; Favre R; Cano JP; Meyer G; Carcassonne Y
    Cancer Chemother Pharmacol; 1986; 17(2):171-6. PubMed ID: 3719898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate kinetics: dose dependent change in clearance following bolus i.v. injection [proceedings].
    Lawrence JR; McVie JG; Steele WH; Stuart JF; Whiting B
    Br J Clin Pharmacol; 1980 Mar; 9(3):290P. PubMed ID: 7362747
    [No Abstract]   [Full Text] [Related]  

  • 9. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis.
    Stewart CF; Fleming RA; Arkin CR; Evans WE
    Clin Pharmacol Ther; 1990 Apr; 47(4):540-6. PubMed ID: 2328562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone modulates pharmacokinetics of low-dose methotrexate in rats.
    Fuksa L; Brcakova E; Cermanova J; Hroch M; Chladek J; Kolouchova G; Malakova J; Martinkova J; Staud F; Micuda S
    Biopharm Drug Dispos; 2008 Jul; 29(5):289-99. PubMed ID: 18548509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of IV hydration with sodium bicarbonate on high-dose methotrexate disposition kinetics].
    Tsuda N; Goto M; Konishi H; Yamashina H
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):873-80. PubMed ID: 6326682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients.
    Joerger M; Huitema AD; van den Bongard HJ; Baas P; Schornagel JH; Schellens JH; Beijnen JH
    Br J Clin Pharmacol; 2006 Jul; 62(1):71-80. PubMed ID: 16842380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid plasma clearance and reduced rate and extent of urinary elimination of parenterally administered methotrexate as a result of severe vomiting and diarrhoea.
    Van Den Berg HW; Murphy RF; Kennedy DG
    Cancer Chemother Pharmacol; 1980; 4(1):47-8. PubMed ID: 7363401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of renal tubular transport of methotrexate by probenecid.
    Bourke RS; Chheda G; Bremer A; Watanabe O; Tower DB
    Cancer Res; 1975 Jan; 35(1):110-6. PubMed ID: 1109785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I evaluation and pharmacokinetic study of pyrazine-2-diazohydroxide administered as a single bolus intravenous injection in patients with advanced solid tumors.
    Supko JG; Balcerzak SP; Kraut EH
    Cancer Res; 1993 Oct; 53(20):4843-9. PubMed ID: 8402671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of methotrexate absorption by subdivision of dose.
    Steele WH; Stuart JF; Lawrence JR; McNeill CA; Sneader WE; Whiting B; Calman KC; McVie JG
    Cancer Chemother Pharmacol; 1979; 3(4):235-7. PubMed ID: 535132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.
    Bannwarth B; Péhourcq F; Schaeverbeke T; Dehais J
    Clin Pharmacokinet; 1996 Mar; 30(3):194-210. PubMed ID: 8882301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of prior cisplatin therapy on the pharmacokinetics of high-dose methotrexate.
    Crom WR; Pratt CB; Green AA; Champion JE; Crom DB; Stewart CF; Evans WE
    J Clin Oncol; 1984 Jun; 2(6):655-61. PubMed ID: 6539365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of methotrexate clearance with an enteral urine alkalinization protocol for patients receiving high-dose methotrexate.
    Kramer E; Filtz M; Pace M
    J Oncol Pharm Pract; 2021 Jan; 27(1):26-32. PubMed ID: 32164493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.